PT  - JOURNAL ARTICLE
AU  - Rene Westhovens
AU  - Lieven Annemans
TI  - Costs of drugs for treatment of rheumatic diseases
AID  - 10.1136/rmdopen-2016-000259
DP  - 2016 Sep 01
TA  - RMD Open
PG  - e000259
VI  - 2
IP  - 2
4099  - http://rmdopen.bmj.com/content/2/2/e000259.short
4100  - http://rmdopen.bmj.com/content/2/2/e000259.full
SO  - RMD Open2016 Sep 01; 2
AB  - The cost of drugs is becoming an issue worldwide, in particular for inflammatory rheumatic diseases. In the current review, an overview of the scene is given with a specific emphasis on accessibility for those patients in real need of the available expensive treatments. The authors propose 7 principles for discussion that need to be addressed and are a responsibility for all stakeholders in rheumatology.